手术量快速增长难抵营收困局 国内手术机器人巨头仍需优化收入结构

21世纪经济报道
15 Jan

近期,国家药监局在14天内批复了9张手术机器人注册证。在2024年12月26日至2025年1月8日期间,骨科获批3张手术机器人注册证,分别来自纳通、和华瑞博和美敦力;穿刺获批2张注册证,都来自真健康;颅脑获批1张注册证,来自安科;口腔获批1张注册证,来自柏惠维康;神经外科获批2张注册证,均来自华科精准。  弗若斯特沙利文估计,未来全球及中国的手术机器人市场规模将会快速增长。其中,预计到2030年,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10